DEVELOPMENT PROCESS
 
2014年  
                  On January 10, Hangzhou Tingke Biotechnology Co., Ltd. was established.
                 The company received funding for the first batch of key support projects under the "5213" plan of Xiaoshan District in 2014
                 The R&D team participated in the sub-project of the National Major Scientific Instrument and Equipment Development
                  Project "Development and Application of Aerospace Medical Fluid Research Equipment".
             In September, the company was recognized as a "Blue Enterprise" in Hangzhou by the Hangzhou Science and Technology
                  Committee.
                 In October, TinkerBio received the first round of angel investment.

2015~2016年  
                Successfully developed two major technology platforms: centrifugal microfluidics and pump-valve driven microfluidics,
                 and three series of microfluidic POCT systems for biochemistry, immunology, and nucleic acid.
                (Fully automatic centrifugal microfluidic biochemical analyzer, centrifugal microfluidic nucleic acid amplification analyzer,
                  handheld microfluidic pesticide residue rapid tester).

2017年  
                  Construction of high molecular polymer (PMMA, PC, PP, COC, PS, etc.) microfluidic chip batch production line.
                 Establish the mass production process of microfluidic chips from mold injection, hot pressing, surface modification,
                  reagent integration, and rapid bonding.       
                 In April, Tingke Biotech received the second round of investment.
                 In August, the company was recognized as a "Hangzhou High-tech Enterprise".

2018年  
                  In January, the company undertook the major scientific and technological project of Xiaoshan District,
                 "Development of a rapid on-site detection system for textile quality and safety based on microfluidic chip technology"
                 In December, the company was recognized as a "National High-tech Enterprise"

2019~2020年    
                 TinkerBio provides microfluidic chip product design, development, processing and production services to
                 hundreds of universities and enterprises at home and abroad, becoming a pioneer in microfluidic chip CDMO

2021年  
                 TinkerBio received the third round of investment.
                 TinrkeBio has built a 1,000-square-meter microfluidic chip R&D laboratory and a 2,000-square-meter microfluidic
                 chip GMP standard production workshop.
                 The R&D team participated in the Zhejiang Province Key R&D Project "R&D of High-Sensitivity Rapid Diagnostic
                 Reagents and Equipment" "New Coronavirus Nucleic Acid Rapid Detection System".
                 In December, the company was recognized as an "International High-tech Enterprise" again after 2018

2022年  
                 In June, TinkerBio successfully passed ISO13485:2016 medical device quality management system certification.
                In June, the Tingke Biotechnology Microfluidic Chip Textile Rapid Testing Project was approved by the Fujian Provincial
                 Science and Technology Department.
               In December, Tingke Bio was awarded the honorary title of "Hangzhou Innovative Small and Medium Enterprises in 2022".

2023年  
                 TinkerBio completed tens of millions of yuan in A+ round financing to accelerate the construction of a microfluidic chip
                 production base.       
                 In March, the pesticide residue rapid tester independently developed by TinkerBio was selected into the "2022 Hangzhou
                 Quality Product Recommendation Catalog".
                In May, TinkerBio was listed in the "2023 Future Medical Top 100 Main List" and was listed in the "China Innovative Business
                and Supply Chain Service Top 100" list.                
               In May, TinkerBio was recognized as a "specialized, refined, innovative and small and medium-sized enterprise in
                Zhejiang Province"
                In May, TinkerBio was recognized as "Hangzhou Tingke Bio Microfluidic Chip Enterprise High-tech Research and
                 Development Center"
                In November, TinkerBionwas approved to establish the "Hangzhou Expert Workstation"
                In November, TinkerBio was identified as a "strategic emerging industry enterprise supported by Xiaoshan District"
                In December, TinkerBio won the "2023 Zhejiang Industry-University-Research Cooperation Innovation Award"

2024年   In January, TinkerBio was approved to establish the "Xiaoshan Economic and Technological Development Zone
                Enterprise Intellectual Property Studio"
                  In August, the "New Coronavirus Nucleic Acid Rapid Detection System", a key R&D project of Zhejiang Province in which
                  TinkerBio participated, successfully passed the acceptance.
Contact Us
Contact: Dr. Judy King    Tel: 13656671373
Email: jdq@tinkerbio.com

Address: No. 198 Qidi Road, Xiaoshan District, Hangzhou City, Zhejiang Province
Room 1707, Building E, Hangzhou Bay Information Port
Follow us on WeChat
About TinkerBio
Company Profile
History
Honor
Patent
Expert Team
Cooperation Unit
Technical Strength
Research Center
Manufacturing Center
Business Matrix
Development Platform
News
TinkerBio News
Industry Information
Product
Biochemical Analysis
Immunoassay
Molecular Diagnostics
Nanosynthesis
Microsphere preparation
Droplet manipulation
Organ Chips
Food Safety and Environmental Protection
Service
Service Introduction
Design and Development
Industrial Development
Business Development